Cvi Holdings, LLC Clene Inc. Transaction History

Cvi Holdings, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.26 - $0.55 $742 - $1,570	2,856 Added 2.64%	111,200 $33,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.87 $31,107 - $58,833	67,625 Added 166.08%	108,344 $54,000
Q2 2023 Aug 11, 2023	BUY	$0.78 - $1.22 $31,760 - $49,677	40,719 New	40,719 $35,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.